Alpha rhythm...................................................................................................31
Antioxidant effect..............................................................................................9
Benign familial infantile epilepsy..................................................................121
Biomarker........................................................................................................37
CADASIL........................................................................................................34
Cardiac conduction disorders.........................................................................105
Cardiac side effect..........................................................................................105
Children............................................................................................................26
Cognitive functions..........................................................................................16
Collective ground sports....................................................................................1
Complete blood parameter indices...................................................................75
Confusional arousal.........................................................................................62
COVID-19 vaccination....................................................................................50
Diagnosis..........................................................................................................56
Digital neuropsychology..................................................................................16
Electrocardiography.......................................................................................105
Electroencephalography...................................................................................26
Engel classification........................................................................................115
Epilepsy................................................1, 26, 37, 46, 50, 56, 75, 79, 83, 96, 126
Epilepsy Disease Concealment Scale..............................................................83
Epilepsy surgery.............................................................................................115
Epileptic paroxysmal arousal...........................................................................62
Focal epileptic seizure......................................................................................34
Fucose..............................................................................................................41
GAERS............................................................................................................69
Gene expression...............................................................................................96
Generalized non-reactive alpha activity...........................................................31
Grey zone.........................................................................................................31
Gymnastic..........................................................................................................1
Hepatotoxicity....................................................................................................9
Hexosamine......................................................................................................41
Hexose..............................................................................................................41
Hyperoxia.........................................................................................................96
Hypothyroidism...............................................................................................46
Idiopathic generalized epilepsy........................................................................16
Inflammation..............................................................................................75, 79
Juvenile myoclonic epilepsy............................................................................87
Lamotrigine....................................................................................................105
Levetiracetam...................................................................................................69
Long-term EEG................................................................................................91
Martial arts.........................................................................................................1
Maternal behavior............................................................................................69
Moringa............................................................................................................41
Neonatal hyperoxia..........................................................................................96
Neurology......................................................................................................105
Neuropsychological evaluation........................................................................87
Nociception....................................................................................................126
Non-convulsive status epilepticus....................................................................31
NOTCH3 gene..................................................................................................34
NREM parasomnias.........................................................................................62
Outdoor sports....................................................................................................1
Oxidative stress..................................................................................................9
Paroxysmal kinesigenic dyskinesia................................................................121
Pfizer biontech.................................................................................................50
Physical exercise................................................................................................1
Platelet..............................................................................................................75
Polytherapy......................................................................................................46
Pregnancy.............................................................................................69, 75, 79
PRRT2............................................................................................................121
Quality of Life Scale in Patients with Epilepsy...............................................83
Relatives.........................................................................................................111
Routine EEG....................................................................................................91
S100B...............................................................................................................37
Salzburg criteria...............................................................................................31
Seizure risk.....................................................................................................111
Seizure-free......................................................................................................91
Sialic acid.........................................................................................................41
Side effect................................................................................................50, 126
Sinovac-coronavac...........................................................................................50
Sleep-related hypermotor epilepsy..................................................................62
Sports.................................................................................................................1
Status epilepticus.............................................................................................21
Status epilepticus etiology...............................................................................21
Status epilepticus in-hospital mortality............................................................21
Stigma..............................................................................................................83
Stomach............................................................................................................41
Sudden unexpected death in epilepsy............................................................111
Survey............................................................................................................111
Synaptopathy..................................................................................................121
Temporal lobe epilepsy..................................................................................115
Trigeminal pain..............................................................................................126
Vagus nerve stimulation.................................................................................126
Valproic acid..........................................................................................9, 41, 69
Video-EEG monitoring....................................................................................56
Video-electroencephalography.........................................................................56
Visual spatial functions....................................................................................87
Vitamin b6..........................................................................................................9
